Former Shinpoong Pharmaceutical CEO Jang Won-jun Sentenced to Prison for Embezzlement

Reporter Kim Jisun / approved : 2025-05-13 03:48:28
  • -
  • +
  • 인쇄

Photo = Yonhap news

 

 

[Alpha Biz= Kim Jisun] Jang Won-jun, former CEO of Shinpoong Pharmaceutical, has been sentenced to prison for embezzling company funds to create a slush fund.



According to legal sources on May 12, the Supreme Court's second division, presided over by Justice Oh Kyung-mi, upheld the lower court's decision on May 1, confirming a sentence of one year and six months in prison for Jang on charges of embezzlement under the Act on the Aggravated Punishment of Specific Economic Crimes.



Prosecutors alleged that from April 2008 to September 2017, Jang created a slush fund totaling KRW 9.1 billion (approx. USD 6.6 million) by inflating the price of raw materials or fabricating transactions to reclaim the difference. The funds were allegedly used for personal expenses and the purchase of company stock.



The first and second trial courts determined that Jang’s late father, former Shinpoong Chairman Jang Yong-taek, had led most of the embezzlement. However, the appeals court found Jang Won-jun guilty of embezzling approximately KRW 860 million (approx. USD 630,000) after March 2016, when his father passed away. He was also convicted of breach of trust involving KRW 86.23 million and of violating the Act on External Audit of Stock Companies by directing the preparation of false financial statements.



Both Jang and the prosecution appealed the decision, but the Supreme Court dismissed the appeals, ruling that the lower court’s findings were legally sound.

 

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Bomb Threats Target Major Korean Companies Including Samsung Electronics2025.12.19
FSS Raises Consumer Alert to “Warning” Over Secondary Scams Linked to Coupang Data Breach2025.12.19
Final U.S. Defense Authorization Bill Omits Provisions Supporting South Korea-Japan Shipbuilding Cooperation2025.12.19
Controversy Surrounds KT’s Former Outside Director Cho Seung-ah Amid Dual Directorship Issue2025.12.19
Samsung Securities Lowers LG Energy Solution Target Price to KRW 480,000 Amid Contract Cancellations2025.12.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사